Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stockholm-based Moberg Derma has entered into a distribution agreement with OzHealth Pharma for Emtrix, a prescription free, topical nail product to treat common nail disorders.
Subscribe to our email newsletter
Emtrix exhibits mechanism of action in which visible improvements are seen within 2-4 weeks of treatment.
Under the agreement OzHealth Pharma will receive rights to market and sell Emtrix in Australia and New Zealand.
Moberg Derma develops patented topical pharmaceuticals for the treatment of common disorders through the use of drug delivery.